Morcellation of the Uterus: Is There Any Place?

Clicks: 279
ID: 273950
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 4 articles by views in Current oncology reports

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
In 2014, the US Food and Drug Administration (FDA) issued a safety communication warning against the use of laparoscopic power morcellators. A risk of occult uterine sarcoma in women is 1/770 to 1/10,000. Our goal is to minimize the risk of spillage due to morcellation and balance it with other risk …
Reference Key
mj2020currentmorcellation Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Halaska MJ;Gracia M;Laky R;Zapardiel I;;
Journal Current oncology reports
Year 2020
DOI
DOI not found
URL
https://www.pubmed.gov/32514869/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female laparoscopy ignacio zapardiel pmid:32514869 doi:10.1007/s11912-020-00927-6 michael j halaska myriam gracia morcellation / adverse effects* morcellation / methods sarcoma / etiology uterine myomectomy / adverse effects* uterine neoplasms / etiology uterus / surgery*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.